<html>
<head>
<title>D075.P.100.B.E.AP881115-0113</title>
</head>
<body bgcolor="white">
<a name="1">[1]</a> <a href="#1" id=1>Phase 2 of the Thrombolysis in Miocardial Infarction Trial, or TIMI-II, has shown that the routine practice of using balloon angioplasty is unnecessary and should be abandoned.</a>
<a name="2">[2]</a> <a href="#2" id=2>The first phase of the study showed that giving tissue plasminogen activator, or TPA, a clot-dissolving drug, right after a heart attack dramatically improved chances of survival.</a>
<a name="3">[3]</a> <a href="#3" id=3>A trial involving a group given angiolplasty and a group given TPA did not show any difference in survival rates after a year.</a>
<a name="4">[4]</a> <a href="#4" id=4>This finding indicates that smaller community hospitals can treat most heart attack patients.</a>
<a name="5">[5]</a> <a href="#5" id=5>Patients needing angioplasty could be transferred to larger hospitals for treatment.</a>
</body>
</html>
